{"id":"https://openalex.org/W1990956265","doi":"https://doi.org/10.1089/neu.1996.13.11","title":"Reduction of the Neurological Deficit in Mice with Traumatic Brain Injury by Nitric Oxide Synthase Inhibitors","display_name":"Reduction of the Neurological Deficit in Mice with Traumatic Brain Injury by Nitric Oxide Synthase Inhibitors","alternate_titles":[],"publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W1990956265","doi":"https://doi.org/10.1089/neu.1996.13.11","mag":"1990956265","pmid":"https://pubmed.ncbi.nlm.nih.gov/8714858"},"language":"en","primary_location":{"id":"doi:10.1089/neu.1996.13.11","doi":"https://doi.org/10.1089/neu.1996.13.11","is_oa":false,"landing_page_url":"https://doi.org/10.1089/neu.1996.13.11","pdf_url":null,"source":{"id":"https://openalex.org/S85864898","display_name":"Journal of Neurotrauma","issn_l":"0897-7151","issn":["0897-7151","1557-9042"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurotrauma","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1990956265"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008153832","display_name":"Christian M\u00e9senge","orcid":"https://orcid.org/0000-0001-8954-4239","observed_orcids":["https://orcid.org/0000-0001-8954-4239"]},"institutions":[{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"CHRISTIAN M\u00c9SENGE","raw_affiliation_strings":["Laboratorie de Pharmacologie, Universit\u00e9 Ren\u00e9 Descartes, Paris, France","Laboratoire de Pharmacologie, Universite Rene Descartes, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorie de Pharmacologie, Universit\u00e9 Ren\u00e9 Descartes, Paris, France","institution_ids":["https://openalex.org/I4387156284"]},{"raw_affiliation_string":"Laboratoire de Pharmacologie, Universite Rene Descartes, Paris, France","institution_ids":["https://openalex.org/I4387156284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111627348","display_name":"CATHERINE VERRECCHIA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"CATHERINE VERRECCHIA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088857600","display_name":"Monique Allix","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"MONIQUE ALLIX","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111821453","display_name":"Roger G Boulu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"ROGER R. BOULU","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5057264297","display_name":"Michel Plotkine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"MICHEL PLOTKINE","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.7811,"has_fulltext":false,"cited_by_count":101,"citation_normalized_percentile":{"value":0.95216387,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"13","issue":"1","first_page":"11","last_page":"16"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10706","display_name":"Traumatic Brain Injury and Neurovascular Disturbances","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10706","display_name":"Traumatic Brain Injury and Neurovascular Disturbances","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10416","display_name":"Traumatic Brain Injury Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/traumatic-brain-injury","display_name":"traumatic brain injury","score":0.9760000109672546},{"id":"https://openalex.org/keywords/nitric-oxide-synthase-inhibitors","display_name":"nitric oxide synthase inhibitors","score":0.9480000138282776},{"id":"https://openalex.org/keywords/l-name","display_name":"L-NAME","score":0.75},{"id":"https://openalex.org/keywords/7-nitroindazole","display_name":"7-nitroindazole","score":0.968999981880188},{"id":"https://openalex.org/keywords/neurological-deficit","display_name":"neurological deficit","score":0.7519999742507935},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9850000143051147},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.8420000076293945},{"id":"https://openalex.org/keywords/l-arginine","display_name":"L-arginine","score":0.8349999785423279},{"id":"https://openalex.org/keywords/closed-head-injury","display_name":"closed head injury","score":0.8429999947547913},{"id":"https://openalex.org/keywords/therapeutic-window","display_name":"therapeutic window","score":0.7739999890327454},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.6579999923706055}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.8442577123641968},{"id":"https://openalex.org/C2781017439","wikidata":"https://www.wikidata.org/wiki/Q1995526","display_name":"Traumatic brain injury","level":2,"score":0.7611730694770813},{"id":"https://openalex.org/C2777622882","wikidata":"https://www.wikidata.org/wiki/Q417619","display_name":"Nitric oxide synthase","level":3,"score":0.7071922421455383},{"id":"https://openalex.org/C2993523616","wikidata":"https://www.wikidata.org/wiki/Q17146697","display_name":"Neurological deficit","level":2,"score":0.6643023490905762},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.551123857498169},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5377028584480286},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5206193923950195},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.49495452642440796},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2784263491630554},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.09217232465744019}],"mesh":[{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001120","descriptor_name":"Arginine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001930","descriptor_name":"Brain Injuries","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D001930","descriptor_name":"Brain Injuries","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019001","descriptor_name":"Nitric Oxide Synthase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019331","descriptor_name":"NG-Nitroarginine Methyl Ester","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1089/neu.1996.13.11","doi":"https://doi.org/10.1089/neu.1996.13.11","is_oa":false,"landing_page_url":"https://doi.org/10.1089/neu.1996.13.11","pdf_url":null,"source":{"id":"https://openalex.org/S85864898","display_name":"Journal of Neurotrauma","issn_l":"0897-7151","issn":["0897-7151","1557-9042"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurotrauma","raw_type":"journal-article"},{"id":"pmid:8714858","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8714858","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurotrauma","raw_type":"Comparative Study"},{"id":"pmid:8860201","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8860201","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurotrauma","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1546521548","https://openalex.org/W1834041853","https://openalex.org/W1929009802","https://openalex.org/W1979994394","https://openalex.org/W2003794997","https://openalex.org/W2024759486","https://openalex.org/W2027463052","https://openalex.org/W2028676745","https://openalex.org/W2037103770","https://openalex.org/W2047362612","https://openalex.org/W2047843548","https://openalex.org/W2050143513","https://openalex.org/W2056031482","https://openalex.org/W2067494203","https://openalex.org/W2074187719","https://openalex.org/W2087916050","https://openalex.org/W2089981038","https://openalex.org/W2127002164","https://openalex.org/W2127764891","https://openalex.org/W2235464535","https://openalex.org/W2409804882"],"related_works":["https://openalex.org/W2019447333","https://openalex.org/W2349586064","https://openalex.org/W2353599262","https://openalex.org/W2075729900","https://openalex.org/W2124481036","https://openalex.org/W265257931","https://openalex.org/W1993128970","https://openalex.org/W3158470188","https://openalex.org/W2058676829","https://openalex.org/W2009232803"],"abstract_inverted_index":{"This":[0],"study":[1],"investigates":[2],"the":[3,6,18,40,44,49,58,63,74,93,139],"effect":[4],"of":[5,33,66,87],"NO":[7,128,132],"synthase":[8,133],"inhibitors,":[9],"NG-nitro-L-arginine":[10],"methyl":[11],"ester":[12],"(L-NAME)":[13],"and":[14,69,79,89],"7-nitroindazole":[15],"(7-NI),":[16],"on":[17],"neurological":[19,45,59,145],"deficit":[20,46,146],"24":[21],"h":[22,112],"after":[23,39,102,113],"a":[24,117],"moderate":[25],"closed":[26],"head":[27],"injury":[28,41],"in":[29,138],"mice.":[30],"Low":[31],"doses":[32],"L-NAME":[34,68,78,88],"or":[35,99],"7-NI":[36,70,80,90],"given":[37,72,96],"soon":[38],"significantly":[42],"reduced":[43],"compared":[47],"to":[48,144],"vehicle-treated":[50],"group.":[51],"L-Arginine":[52],"(300":[53],"mg/kg)":[54],"did":[55],"not":[56,106],"alter":[57],"deficit,":[60],"but":[61,105],"reversed":[62],"protective":[64],"effects":[65,86],"both":[67,122],"when":[71,92,107],"at":[73],"same":[75],"time.":[76],"Both":[77],"had":[81],"dose-related":[82],"effects.":[83],"The":[84],"neuroprotective":[85],"occurred":[91],"drugs":[94],"were":[95],"5,":[97],"30,":[98],"60":[100],"min":[101],"brain":[103,114,149],"injury,":[104,115],"treatment":[108],"was":[109],"begun":[110],"2":[111],"suggesting":[116],"short":[118],"therapeutic":[119],"window":[120],"for":[121],"drugs.":[123],"These":[124],"results":[125],"suggest":[126],"that":[127],"synthesis":[129],"by":[130],"neuronal":[131],"plays":[134],"an":[135],"important":[136],"role":[137],"early":[140],"neurotoxic":[141],"cascade":[142],"leading":[143],"following":[147],"traumatic":[148],"injury.":[150]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1990956265","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
